KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Capital Employed (2016 - 2025)

Neogenomics' Return on Capital Employed history spans 15 years, with the latest figure at 0.09% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 2.0% year-over-year to 0.09%; the TTM value through Dec 2025 reached 0.09%, down 2.0%, while the annual FY2025 figure was 0.08%, 1.0% down from the prior year.
  • Return on Capital Employed reached 0.09% in Q4 2025 per NEO's latest filing, up from 0.09% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.02% in Q2 2021 to a low of 0.1% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.07%, with a median of 0.07% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: dropped -8bps in 2022, then rose 3bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.07% in 2021, then plummeted by -44bps to 0.1% in 2022, then grew by 28bps to 0.07% in 2023, then dropped by -1bps to 0.07% in 2024, then crashed by -32bps to 0.09% in 2025.
  • Per Business Quant, the three most recent readings for NEO's Return on Capital Employed are 0.09% (Q4 2025), 0.09% (Q3 2025), and 0.08% (Q2 2025).